BCM
CAVM

Bayesian Capital Management’s Cavium, Inc. CAVM Stock Holding History

Bayesian Capital Management’s Portfolio CAVM Stock Details CAVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-3,945
Closed -$260K – 824
2017
Q3 		$260K Buy
+3,945
New +$250K 0.06% 392
2016
Q2 		– Sell
-5,967
Closed -$365K – 631
2016
Q1 		$365K Buy
+5,967
New +$344K 0.34% 101

Other funds holding CAVM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

Bayesian Capital Management's CAVM Position: Q4 2017 in Review

Bayesian Capital Management sold out of Cavium, Inc. (CAVM) in Q4 2017, closing a stake of 3,945 shares — an estimated $260K sold.

Bayesian Capital Management first reported a position in CAVM in Q1 2016 and held it in 2 quarters. The position peaked at $365K in Q1 2016. 264 funds tracked by Wall St. Rank hold CAVM as of Q4 2017.

  • Bayesian Capital Management reported no remaining Cavium, Inc. position as of Q4 2017 after selling out during the quarter.
  • Bayesian Capital Management sold 3,945 Cavium, Inc. shares in Q4 2017, an estimated $260K.
  • Bayesian Capital Management first reported a position in Cavium, Inc. in Q1 2016 and held it in 2 quarters.
  • Bayesian Capital Management's Cavium, Inc. position peaked at $365K in Q1 2016.
  • 264 funds tracked by Wall St. Rank held Cavium, Inc. as of Q4 2017.

Based on Bayesian Capital Management's 13F filing for Q4 2017, filed 12 Feb 2018.